Elevated levels of ribonucleases in serum of patients with liver disease

Saudi Medical Journal

Volumn 17, Issue 1, 1996, Pages 42-46

  Karawya, Essam M ^a,b   Al Wabel, Abdul Hameed A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Faculty of Pathological Sciences

Author keywords

Encephalopathy; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Hepatosplenomegaly; Liver hydatid; Ribonucleases

Indexed keywords

EID: 1842363322     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Berk PD, Javitt NB. Hyperbilirubineamia and cholestasis. Am J Med 1978; 64: 311-326.
2. Clermont RJ, Chalmers TC. The transaminase test in liver disease. Medicine 1967; 46: 197-207.
3. Becker KI, Stauffer MH. Evaluation of concentrations of serum alkaline phosphatase in hepatitis and obstructive jaundice. Am. J. Med. Sci. 1962; 243: 222-229.
4. Koller F. Theory and experience behind the use of Coagulation test in diagnosis and prognosis of liver disease. Scand J Gastroenterology. 1973; 8 (19): 51-61.
5. Beckett GJ, Dyson EH, Templeton AJ, Hayes JD. Plasma glutathione S, transfer ease measurements by radioimmunoassay. A sensitive index of hepatocellular damage in man. Clin Chim Acta 1985; 146: 11-19.
6. Hill PG, Sammons HG. An assessment of 5′-nucleotidase as a liver-function test. Quart J Med 1967; 36: 457-468.
7. Zimmerman HJ, Seef LB. Enzymes in hepatic disease. In: Coodley EL (ed) Diagnostic enzymology. Lea & Febiger, Philadelphia, 1970: 1-40.
8. Reddi KK, Holland JF. Elevated serum ribonuclease in patients with pancreatic cancer. Proc Nat Acad Sci USA 1976; 73; 2308-2310.
9. Akagi K, Yamanaka M, Murai K, Niho Y, Omae T. Serum acid ribonuclease in meyelogenous leukemia. Cancer Res 1978; 38: 2168-2173.
10. Fink K, Adams WS, Skoog WA. Serum ribonuclease in multiple myeloma. Am. J. Med. 1971; 50: 450-457.
11. Drake WP, Schmukler M, Pendergrast WJ, Davis AS, Lichenfeld JL, Mardiny MR. Abnormal profile of human nucleolytic activity as a test for cancer. JNCI 1975; 55: 1055-1059.
12. Mitsushashi F, Araki E. Serum RNase activity in patients with malignancy and non-malignant diseases JPN J Clin Oncol 1980; 10: 235-240.
13. Sznajd J, Magdon M, Naskalski J, Uracz R, Wojcikiewicz O, Serum ribonuclease activity in acute myocardial infarction. Cor Vass 1981; 23: 241-247.
14. Reddi KK. Serum ribonuclease of normal persons and patients with renal impairment. Clin Biochem 1978; 11: 133-134.
15. Sommer H, Gang V, Heidland A. Serum ribonuclease activity in patients during parenteral nutrition, chronic hemodialysis and acute pancreatitis. Klin Wochenschr 1977, 55: 1019-1020.
16. Deutscher MP. The metabolic role of RNases. Trends Biochem Sci 1988; 13:136-139.
17. Benner SA. Extracellular "communicator RNA". FEBS Lett 1988; 233: 225-228.
18. Benner SA, Allemann RK. The return of pancreatic ribonucleases. Trends Biochem. Sci 1989; 14: 396-397.
19. Akagi K, Murai K, Hirao N, Yamanaka M. Purification and properties of alkaline ribonuclease from human serum. Biochim Biophys. Acta. 1976; 442:368-378.
20. De lamirande G, Allard C, Da Costa HC, Cantero A. Intracellular distribution of acid and alkaline ribonucleases in normal rat liver. Science 1954; 119:351-353.
21. Reid E, Nodes JT. Liver ribonucleases. Ann NYAcad. Sci. 1959; 81: 618.
22. Postek KM, La Due T, Nelson C, Sandwick RK. Spectrophotometric ribonuclease assays using dinucleoside monophosphate substrates Anal Biochem 1992; 203: 47-52.
23. Francesconi M, Meryn S, Rogan AM, Szalay S, Granigner W, Schmidbauer CP. Poly (c) avid ribonuclease estimation in patients with solid tumors. A critical evaluation. Cancer 1984; 53: 1927-1930.